These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 29605543)
1. Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole. Król J; Nawrot U; Bartoszewicz M J Mycol Med; 2018 Jun; 28(2):327-331. PubMed ID: 29605543 [TBL] [Abstract][Full Text] [Related]
2. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D; Coste AT Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study. Lei J; Xu J; Wang T J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520 [TBL] [Abstract][Full Text] [Related]
4. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents. Chen TC; Chen YH; Chen YC; Lu PL Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates. Astvad KMT; Hare RK; Arendrup MC Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148 [TBL] [Abstract][Full Text] [Related]
6. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp]. Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462 [TBL] [Abstract][Full Text] [Related]
8. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Seifert H; Aurbach U; Stefanik D; Cornely O Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977 [TBL] [Abstract][Full Text] [Related]
9. In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds. Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M J Clin Microbiol; 2013 Aug; 51(8):2608-16. PubMed ID: 23740727 [TBL] [Abstract][Full Text] [Related]
10. Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect. Marcos-Zambrano LJ; Gómez A; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J Clin Microbiol Infect; 2018 Dec; 24(12):1343.e1-1343.e4. PubMed ID: 30025834 [TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp]. Ricciardi AM; Ricciardi R; Danzi M; Mungiguerra M; Pisano L; Marino A Infez Med; 2009 Mar; 17(1):24-7. PubMed ID: 19359821 [TBL] [Abstract][Full Text] [Related]
12. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. Pina-Vaz C; Rodrigues AG; Costa-de-Oliveira S; Ricardo E; Mårdh PA J Antimicrob Chemother; 2005 Oct; 56(4):678-85. PubMed ID: 16115827 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei. Drago M; Scaltrito MM; Morace G; Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831 [TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
15. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926 [TBL] [Abstract][Full Text] [Related]
16. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole. Nguyen MH; Yu CY J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846 [TBL] [Abstract][Full Text] [Related]
17. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Dagi HT; Findik D; Senkeles C; Arslan U Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756 [TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027 [TBL] [Abstract][Full Text] [Related]
19. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
20. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]